Skip to main content
Log in

Diatrizoate compounds (urografin) treatment for sudden hearing loss

  • Published:
Indian Journal of Otolaryngology Aims and scope Submit manuscript

Abstract

Twentyeight (28) patients with Idiopathic sudden hearing loss (SHL) were treated with Diatrizoate compounds (1 ml urografin 76%) containing—sodium Diatrizoate 0.1g & Meglumine Diatrizoate 0.66g after complete clinical and audiological evaluation. All the patients of SHL of not more than 45 days of onset were selected. Of these patients 19 cases (67.7%) had beneficial response with Diatrizoate Compounds (Urografin) Treatment. These patients were followed up to 4 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Emmett J. R. & Shea J.J. (1979), Diatrizoate Meglumine (Hypaque) Treatment for SHL,Laryngoscope,89: 1229–1238.

    PubMed  CAS  Google Scholar 

  2. Morimitsu T. (1977), New Theory and Treatment for sudden deafness. In proceeding of the Shambaugh V International Workshop on Middle-Ear Miccrosurgery and Fluctuant Hearing Loss: G. E. Shambaugh and J. J. Shea (eds)Strode publishers, Inc, Huntsrille, Ala, pp 412–421.

    Google Scholar 

  3. Shea J. J. and Emmett J. R. (1977), Evaluation of Diatrizoate Meglumine (Hypaque) in treatment of SHLLaryngoscope,87: 1809–1814.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Talsania, J.R., Ranade, P.N. Diatrizoate compounds (urografin) treatment for sudden hearing loss. Indian J Otolaryngol 41, 100–103 (1989). https://doi.org/10.1007/BF02994223

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02994223

Keywords

Navigation